Please sign in to follow a disease.
Stromal corneal dystrophy
MONDO:0020213The stromal corneal dystrophies refer to a group of rare genetically determined corneal dystrophies (CDs) characterized by lesions affecting the corneal stroma, and variable effects on vision depending on the type of dystrophy.
Also known as: corneal dystrophy (disease) of substantia propria of cornea, corneal stromal dystrophy, substantia propria of cornea corneal dystrophy (disease), stromal dystrophy
23 clinical trials for this condition and its sub-types, 2 tagged with Stromal corneal dystrophy itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Stromal corneal dystrophy
-
Macular corneal dystrophy 13 trials
-
Fleck corneal dystrophy 1 trial
-
Schnyder corneal dystrophy 0 trials
-
Central cloudy dystrophy of François 0 trials
-
Congenital stromal corneal dystrophy 0 trials
-
Granular corneal dystrophy type I 0 trials
-
Granular corneal dystrophy type II 0 trials
-
Lattice corneal dystrophy 0 trials
3 sub-types
- Corneal dystrophy, lattice type 3A 0 trials
- Gelatinous drop-like corneal dystrophy 0 trials
- Lattice corneal dystrophy type I 0 trials
-
Pre-descemet corneal dystrophy 0 trials
-
Experimental drug combo tested for rare, deadly castleman disease
Disease control OngoingThis study looks at a rare disease called KSHV-associated multicentric Castleman's disease (MCD), caused by a virus. Researchers are testing several drug combinations, including chemotherapy and antivirals, to see if they can control the disease. The study also tracks how the dis…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Rapamycin drug tested for rare castleman disease
Disease control OngoingThis phase 2 study tests the drug sirolimus (rapamycin) in 7 people with idiopathic multicentric Castleman disease who have not improved with standard therapy. The goal is to see if sirolimus can improve symptoms like fatigue, fever, and night sweats, and shrink enlarged lymph no…
Phase 2 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Can a donor lens implant restore clarity to clouded corneas?
Disease control By invitation onlyThis trial investigates whether implanting a fresh corneal lenticule — a thin layer of donor cornea taken from myopic patients — can improve transparency and vision in people with macular corneal dystrophy, a condition that clouds the cornea. Using a femtosecond laser, surgeons r…
Sponsor: Eye Hospital Pristina Kosovo • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC